Helios Bioelectronics Inc.
Update：2026/08/06
Industries
Main Industry
Biotechnology
Main Product/Service
1. CMOS-Based Biochip System
Developed in collaboration with TSMC, the CMOS (Complementary Metal-Oxide-Semiconductor) biochip system is designed for multiplexing, enabling simultaneous detection of multiple biomarkers and rapid collection of extensive bi
Developed in collaboration with TSMC, the CMOS (Complementary Metal-Oxide-Semiconductor) biochip system is designed for multiplexing, enabling simultaneous detection of multiple biomarkers and rapid collection of extensive bi
Founded Year
2016
Unified Business No.
45120064
Status
Active
Number of Employees
23
Total Paid-in
Capital
136,302,456 (NT$)
Location of Company
Taiwan
, Hsinchu County
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Helios Bioelectronics Inc. Company IntroductionFounded in 2016, Helios Bioelectronics Inc. is an innovative biotechnology company dedicated to integrating semiconductor technology with biomarker detection.
The company’s initial goal was to combine advanced semiconductor technology with biological diagnostics to develop efficient and precise diagnostic tools, advancing healthcare and drug development. Through collaborations with Taiwan Semiconductor Manufacturing Company (TSMC) and Episil Technologies, Helios has successfully developed two cutting-edge biochip systems, demonstrating its exceptional capability in merging biotechnology with semiconductor technology.
The company’s initial goal was to combine advanced semiconductor technology with biological diagnostics to develop efficient and precise diagnostic tools, advancing healthcare and drug development. Through collaborations with Taiwan Semiconductor Manufacturing Company (TSMC) and Episil Technologies, Helios has successfully developed two cutting-edge biochip systems, demonstrating its exceptional capability in merging biotechnology with semiconductor technology.
